| Style | Citing Format |
|---|---|
| MLA | Tsatsakis A, et al.. "An Expert Criticism on Post-Publication Peer Review Platforms: The Case of Pubpeer." DARU, Journal of Pharmaceutical Sciences, vol. 34, no. 1, 2026, pp. -. |
| APA | Tsatsakis A, Aschner M, Sarigiannis D, Docea AO, Rezaee R, Daghighi SM, Svistunov AA, Domingo JL, Abdollahi M (2026). An Expert Criticism on Post-Publication Peer Review Platforms: The Case of Pubpeer. DARU, Journal of Pharmaceutical Sciences, 34(1), -. |
| Chicago | Tsatsakis A, Aschner M, Sarigiannis D, Docea AO, Rezaee R, Daghighi SM, Svistunov AA, Domingo JL, Abdollahi M. "An Expert Criticism on Post-Publication Peer Review Platforms: The Case of Pubpeer." DARU, Journal of Pharmaceutical Sciences 34, no. 1 (2026): -. |
| Harvard | Tsatsakis A et al. (2026) 'An Expert Criticism on Post-Publication Peer Review Platforms: The Case of Pubpeer', DARU, Journal of Pharmaceutical Sciences, 34(1), pp. -. |
| Vancouver | Tsatsakis A, Aschner M, Sarigiannis D, Docea AO, Rezaee R, Daghighi SM, et al.. An Expert Criticism on Post-Publication Peer Review Platforms: The Case of Pubpeer. DARU, Journal of Pharmaceutical Sciences. 2026;34(1):-. |
| BibTex | @article{ author = {Tsatsakis A and Aschner M and Sarigiannis D and Docea AO and Rezaee R and Daghighi SM and Svistunov AA and Domingo JL and Abdollahi M}, title = {An Expert Criticism on Post-Publication Peer Review Platforms: The Case of Pubpeer}, journal = {DARU, Journal of Pharmaceutical Sciences}, volume = {34}, number = {1}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Tsatsakis A AU - Aschner M AU - Sarigiannis D AU - Docea AO AU - Rezaee R AU - Daghighi SM AU - Svistunov AA AU - Domingo JL AU - Abdollahi M TI - An Expert Criticism on Post-Publication Peer Review Platforms: The Case of Pubpeer JO - DARU, Journal of Pharmaceutical Sciences VL - 34 IS - 1 SP - EP - PY - 2026 ER - |